A meta-analysis of the association of G915C, G800A, C509T gene polymorphism of transforming growth factor-β1 with diabetic nephropathy risk

Renal Failure

Volumn 36, Issue 2, 2014, Pages 321-326

  Zhang, Jie ^a   Guan, Ya Li ^b   Xiao, Yan ^a   Zhang, Xian Wen ^c  

^a Information and Engineering   (China)

^b Department of Children's Rehabilitation   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

C509T; Diabetic nephropathy; G800A; G915C; Gene polymorphism; Meta analysis; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

DIABETIC NEPHROPATHY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; META ANALYSIS (TOPIC); PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84896724142     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.832320     Document Type: Review

References (23)

1. Kong LL, Wu H, Cui WP, et al. Advances in murine models of diabetic nephropathy. J Diabetes Res. 2013;2013:797548.
2. Yu ZY, Chen LS, Zhang LC, Zhou TB. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy. Nephrology (Carlton). 2012;17:480-487.
3. Zhou TB, Xu HL, Yin SS. Association between endothelial nitric oxide synthase Glu298Asp gene polymorphism and diabetic nephropathy susceptibility. Ren Fail. 2013;35:173-178.
4. Chang WW, Zhang L, Yao YS, Su H, Jin YL, Chen Y. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and susceptibility to diabetic nephropathy in Chinese type 2 diabetic patients: a meta-analysis. Ren Fail. 2013;35:1038-1043.
5. Zhao Y, Yang J, Zhang L, et al. Association between TNF-alpha -308G/A polymorphism and diabetic nephropathy risk: a metaanalysis. Int Urol Nephrol. 2013. [Epub ahead of print]. doi: 10.1007/s11255-013-0490-3.
6. Zhou TB, Liu YG, Lin N, et al. Relationship between angiotensinconverting enzyme insertion/deletion gene polymorphism and systemic lupus erythematosus/lupus nephritis: a systematic review and metaanalysis. J Rheumatol. 2012;39:686-693.
7. Zhou TB, Qin YH, Su LN, et al. The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: a systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst. 2011;12: 624-633.
8. Zhu JM, Wang B, Li J, et al. D18S880 microsatellite polymorphism of carnosinase gene and diabetic nephropathy: a meta-analysis. Genet Test Mol Biomarkers. 2013;17:289-294.
9. Hou YL, Chen H, Dong ZH, et al. Clinical significance of serum transforming growth factor-beta1 in lung cancer. Cancer Epidemiol. 2013. [Epub ahead of print]. doi: 10.1016/j.canep.2013.04.013.
10. Zhou TB, Qin YH, Lei FY, Su LN, Zhao YJ, Huang WF. ApoE expression in glomerulus and correlation with glomerulosclerosis induced by adriamycin in rats. Ren Fail. 2011;33:348-354.
11. Zhou TB, Qin YH, Su LN, et al. Insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme gene in steroidresistant nephrotic syndrome for children: a genetic association study and meta-analysis. Ren Fail. 2011;33:741-748.
12. Zhou TB, Qin YH, Xu HL. Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: a meta-analysis of experimental and human studies. Mol Biol Rep. 2012;39:9347-9354.
13. Buraczynska M, Baranowicz-Gaszczyk I, Borowicz E, Ksiazek A. TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes. Nephron Physiol. 2007;106:69-75.
14. El-Sherbini SM, Shahen SM, Mosaad YM, Abdelgawad MS, Talaat RM. Gene polymorphism of transforming growth factor-beta1 in Egyptian patients with type 2 diabetes and diabetic nephropathy. Acta Biochim Biophys Sin (Shanghai). 2013;45:330-338.
15. McKnight AJ, Savage DA, Patterson CC, Sadlier D, Maxwell AP. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy. BMC Med Genet. 2007;8:5.
16. Ng DP, Warram JH, Krolewski AS. TGF-beta 1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: an investigation of multiple known DNA sequence variants. Am J Kidney Dis. 2003;41:22-28.
17. Rao W, Jian X, Zhou W. The relationship between transforming growth factor-b1 gene polymorphism and diabetic nephropathy risk in Guangdong Han population. Int Med Health Guidance News. 2011;17:654-656.
18. Valladares-Salgado A, Angeles-Martinez J, Rosas M, et al. Association of polymorphisms within the transforming growth factor-beta1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations. Nephrology (Carlton). 2010;15: 644-648.
19. Wei Y, Lan Y, You Y, et al. The serum level and the genotype of TGF-b1 in patients with type 2 diabetic nephropathy. Chin J Lab Med. 2005;28:173-177.
20. Jia H, Yu L, Gao B, Ji Q. Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis. Endocrine. 2011;40:372-378.
21. Yang S, Zhang J, Feng C, Huang G. MTHFR 677T variant contributes to diabetic nephropathy risk in Caucasian individuals with type 2 diabetes: a meta-analysis. Metabolism. 2013;62: 586-594.
22. Cui W, Du B, Zhou W, et al. Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis. Mol Biol Rep. 2012;39: 8551-8558.
23. Wang L, Teng Z, Cai S, et al. The association between the PPARgamma2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9176 subjects. Diagn Pathol. 2013;8:118.